Sunday, 14 August 2022
quote [ The FDA also detailed other options that the agency had considered. But the use of alternative vaccines to prevent monkeypox "was determined to be either impractical or inadvisable at this time," according to the letter. Specifically, the ACAM2000 vaccine, which is FDA approved for prevention of smallpox, "may not be appropriate now for a potentially immunocompromised population," the letter said. ]
|
Totally, totally unrelated:
With new guidance, CDC ends test-to-stay for schools and relaxes COVID rules